BB Research Absolute
LU0865910573 · BB Research Absolute I CHF
n/a
6M return
No performance history for this class yet.
← Edit selection
Comparing 3 funds
Returns, costs and exposure side by side, with sources and dates below.
BB Europe Equity Market Neutral
LU1947777527 · BB Europe Equity Market Neutral HB CHF
n/a
6M return
No performance history for this class yet.
BB Adamant Global Generics
LU1318738918 · BB Adamant Global Generics I CHF
n/a
6M return
No performance history for this class yet.
Performance, starting at 100
GBP total return, daily prices. Source: FE fundinfo. Past performance is not a reliable guide to future returns.
If you had invested £10,000
What it would have become over 6M, GBP.
Based on month end returns. Illustrative, before tax, not a prediction.
Country exposure
No allocation data for these funds
Not available for: BB Research Absolute, BB Europe Equity Market Neutral, BB Adamant Global Generics.
Sector exposure
No allocation data for these funds
Not available for: BB Research Absolute, BB Europe Equity Market Neutral, BB Adamant Global Generics.
AI comparison
AI assisted, not advice. Describes the data on this page.
Select Summarise differences for a short, neutral description of how these funds differ on the figures below.
Side by side
Returns in GBP, month end. Bold marks the highest value in the return rows, the lowest in the ongoing charge row and the largest in the fund size row.
| Metric | BB Research Absolute | BB Europe Equity Market Neutral | BB Adamant Global Generics |
|---|---|---|---|
| 1 year returnHighest in bold | n/a | n/a | n/a |
| 3 year returnHighest in bold | n/a | n/a | n/a |
| 5 year returnHighest in bold | n/a | n/a | n/a |
| Rank among sector peers, 1 yearQuartile among representative funds in the FE sector | n/a | n/a | n/a |
| Ongoing charge (OCF) | |||
| Fund size, GBPLargest in bold | £6.5M | £321K | n/a |
| Style | n/a | n/a | n/a |
| FE sector | n/a | n/a | n/a |
| Share class | BB Research Absolute I CHF | BB Europe Equity Market Neutral HB CHF | BB Adamant Global Generics I CHF |